Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walking and resistance bands show promise for breast cancer recovery

NCT ID NCT07338903

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a 12-week home-based program of walking and resistance band exercises could improve physical fitness, fatigue, and quality of life for 36 breast cancer patients in Indonesia. Participants used pedometers and resistance bands at home, with weekly phone check-ins and hospital visits every four weeks. The goal was to see if this approach is feasible and beneficial in a real-world setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
home-based aerobic (walking) and resistance training (therapeutic bands)
What this could lead to
If successful, this approach could offer a simple, low-cost way to improve physical fitness and reduce fatigue for breast cancer survivors in Indonesia.
What could go wrong
This is a small feasibility study with only 36 participants, so results may not apply to all patients. The exercise program relies on self-motivation and may be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Jan 2022

Finished

Feb 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

17 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with stage I-III hormone-receptor positive breast cancer * Eastern Cooperative Oncology Group (ECOG) score ≤1 * Had completed primary treatment (e.g., surgery, chemotherapy, and radiotherapy), except for hormonal treatment * Within 5 years of diagnosis * Able to perform moderate-intensity physical activity as determined by their oncologist and care team * Able to read and write in Indonesian * Willing to provide written informed consent. Exclusion Criteria: * Had an ejection fraction of \<50% * Evidence of cardiac disease, severe musculoskeletal problems, or other contraindications for exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Sardjito General Hospital

    Sleman, Yogyakarta Special Region, 55284, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.